Kristen Metivier’s scientific contributions

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (1)


Intensive Care Management of Acute Ischemic Stroke
  • Literature Review

August 2012

·

598 Reads

·

26 Citations

Emergency Medicine Clinics of North America

·

Deborah M Green

·

Kristen Metivier

·

Christina Defusco

Despite the success of acute reperfusion therapies for the treatment of acute ischemic stroke, only a minority of patients receive such treatment. Even patients who receive reperfusion therapy remain at risk for further neuronal death through progressive infarction and secondary injury mechanisms. The goal of neurocritical care for the patient with acute ischemic stroke is to optimize long-term outcomes by minimizing the amount of brain tissue that is lost to these processes. This is accomplished by optimizing brain perfusion, limiting secondary brain injury, and compensating for associated dysfunction in other organ systems. Because of the rapid and irreversible nature of ischemic brain injury, it is crucial for best neurocritical care practices to begin as early as possible. Therefore, this chapter will discuss optimal, pragmatic neurocritical care management of patients with acute ischemic stroke during the "golden" emergency department hours from the perspective of the neurointensivist. Major topics include cerebral perfusion optimization; management of cerebral edema; post-thrombolytic care; acute anticoagulation; treatment of commonly associated cardiac and pulmonary complications; fluid, electrolyte and glucose management; the role of induced normothermia and therapeutic hypothermia; and prophylaxis against common complications.

Citations (1)


... Most patients suffer from motor impairment after stroke, which affects their quality of life (10,11). Thrombolytic therapy (as the only treatment proven to improve the outcome of such patients) is feasible only in a minority of clinical cases (12)(13)(14). Even with the use of this drug, more than half of IS patients are still disabled (15,16). ...

Reference:

Investigating the Effect of Citalopram and Fluoxetine on Motor Function after Stroke in Patients with Acute Cerebral Stroke
Intensive Care Management of Acute Ischemic Stroke
  • Citing Article
  • August 2012

Emergency Medicine Clinics of North America